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Abstract
Next-generation sequencing allows for a new focus on rare variant density for conducting analyses of association to
disease and for narrowing down the genomic regions that show evidence of functionality. In this study we use the
1000 Genomes Project pilot data as distributed by Genetic Analysis Workshop 17 to compare rare variant densities
across seven populations. We made the comparisons using regressions of rare variants on total variant counts per gene
for each population and Tajima’s D values calculated for each gene in each population, using data on 3,205 genes. We
found that the populations clustered by continent for both the regression slopes and Tajima’s D values, with the African
populations (Yoruba and Luhya) showing the highest density of rare variants, followed by the Asian populations (Han
and Denver Chinese followed by the Japanese) and the European populations (CEPH [European-descent] and Tuscan)
with the lowest densities. These significant differences in rare variant densities across populations seem to translate to
measures of the rare variant density more commonly used in rare variant association analyses, suggesting the need to
adjust for ancestry in such analyses. The selection signal was high for AHNAK, HLA-A, RANBP2,a n dRGPD4, among others.
RANBP2 and RGPD4 showed a marked difference in rare variant density and potential selection between the Luhya and
the other populations. This may suggest that differences between populations should be considered when delimiting
genomic regions according to functionality and that these differences can create potential for disease heterogeneity.
Background
Genome-wide association studies have proven to be suc-
cessful in identifying some of the common variants that
contribute to complex disease. Nevertheless, most of the
variation underlying complex disease has yet to be discov-
ered. Focus is starting to shift toward capturing other types
of variation. The new next-generation sequencing technol-
ogy allows for the identification of rare variants across
many individuals and for their use in studies of association
to disease. This new technology also allows for the study of
patterns of sequence variation that can point to functional
regions in the genome, which can then be targeted in can-
didate gene and pathway association analyses. Incorporat-
ing a priori knowledge about functionality across genomic
regions lowers the number of association tests conducted
in the usual genome-wide association studies, thereby
increasing their power.
Rare variant association analysis can be conducted under
the premise that rare variants are deleterious and that
their presence in individuals increases risk of disease. Sev-
eral approaches to comparing counts of rare variants
between case and control subjects have been proposed,
including individual- and group-based measures of diver-
sity [1,2]. One such measure could be the number of rare
variants for the group relative to the total number of poly-
morphic sites. Differences between populations in the gen-
ome-wide density of rare variants can confound rare
variant association analysis, and such differences between
populations have yet to be described.
Rare variant density can also be used to narrow down
the functional regions within the genome. Neutrality the-
ory suggests that most mutations are selectively neutral;
that is, the allele frequency distribution observed for a
population is the result of a balance between the acquisi-
tion of new mutations and the loss of mutations as a
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measure used to gauge excess or deficiency of rare
variants under the null model of neutral evolution [4].
Populations that differ in their environmental histories
and that present some genome-wide divergence (and
therefore different genomic contexts) can vary with
respect to the regions or genes that undergo selection
[5]. These differences may be relevant for studies that
attempt to incorporate regional genomic functionality
into the study’s design.
In this paper we look at the patterns of rare variant den-
sity across the genome using the sequencing data obtained
by the 1000 Genomes Project [6] and distributed by
Genetic Analysis Workshop 17 (GAW17) for 3,205 genes
across seven populations: CEPH (a European-descent
population from Utah) (n = 90), Denver Chinese (n =
107), Han Chinese (n = 109), Japanese (n = 105), Luhya
(n = 108), Tuscan (n = 66), and Yoruba (n = 112). We
examine differences in rare variant distribution between
populations and discuss their implications for rare variant
association analysis and for inferring genome region
functionality.
Methods
Rare to total variant ratios across genes and populations
Rare variant counts (single-nucleotide polymorphisms
[SNPs] with minor allele frequencies [MAFs] less than
0.05) and total variant counts (total number of SNPs)
are calculated for each of the 3,205 genes (i = 1:3,205)
for each population individually and for the seven popu-
lations pooled (j = 1:8). A linear regression between
these two measures gives an estimate for the slope B,
which characterizes their relationship:
Rare variants (i, j)=B(j) × Total variants (i, j)+e(i, j). (1)
Differences between population slopes are tested for
significance using the Student’s t-test statistic, computed
as the difference between the slope estimates (B) divided
by the standard error (SE) of this difference:
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The same analysis is carried out using synonymous
and nonsynonymous SNPs separately.
Individual-based rare variant density measures
The Yoruba and CEPH populations are contrasted with
respect to their rare variant density across individuals.
The proportion of individuals with rare variants is com-
puted for each of the 3,205 genes as the number of indi-
viduals who have at least one rare variant for the gene
for their population divided by the total number of indi-
viduals in the population. The average number of rare
variants per individual for each of the genes is computed
by summing the number of rare variants present in each
individual for the gene and dividing by the total number
of individuals in the population. A paired t test is used
to compare the two populations.
Tajima’s D
Two measures of nucleotide diversity are θ and π. θ is
the total number of segregating sites and is given by:
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where S is the number of segregating sites in gene and
n is the population size. π is based on the levels of het-
erozygosity at the individual sites and is given by:
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These two measures are contrasted in Tajima’s D
value:
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The variance of the difference between these two mea-
sures is computed as described by Tajima [4].
Our analysis was made using nonsynonymous and
synonymous SNPs separately. All computations were
carried out through programming with R software using
its standard base packages.
Results
We found significant differences for the slopes describing
the relationship between rare variants and total variants
per gene across populations in the analysis using all SNPs
(Figure 1; Table 1). The only exceptions are the compari-
son between the Han and the Denver Chinese populations
and that between the Luhya and Yoruba populations,
which do not present significant differences. Because these
differences in slope reflect the overall rare variant density
throughout the genome, demographic differences between
the populations rather than selection differences are likely
responsible for the result. The Luhya and Yoruba popula-
tions have the highest slopes, representing a higher load of
rare variants relative to the number of polymorphisms,
whereas the Tuscan and CEPH populations present the
lowest slopes. When all the populations are pooled, the
slope becomes significantly higher.
For the pooled analysis, we found that the outlying
genes were AHNAK, which had the greatest number of
rare variants per total number of variants compared to
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the least number of rare variants per total number of
variants.
The rare variant to total variant slopes and Tajima’s D
values for the nonsynonymous and synonymous SNPs
group the populations in a similar way (see Table 1).
The Tuscan and CEPH populations present the lowest
density of rare variants, with their lower slope values
and higher D means, followed by the Japanese popula-
tion. The Chinese populations present an intermediate
value, and the African Yoruba and Luhya populations
have the highest slopes and most negative D values.
For the separate analyses on synonymous and nonsy-
nonymous SNPs, we obtained larger differences between
population slopes when we used the synonymous SNPs
(Figure 2). The analysis with synonymous SNPs presents a
similar pattern and similar statistical significance to the
analysis using all SNPs. For the analysis using only nonsy-
nonymous SNPs, we found that only the Tuscan and
CEPH populations had significantly different slopes com-
pared to each other and to the rest of the populations.
As with the group-based rare variant density measure
represented in the rare variant to total variant regres-
sions, the individual-based rare variant density measures
Figure 1 Rare variant density for each population and all populations pooled using all available SNPs. The slope for the linear regression
of rare variants on total variants per gene for all populations pooled is shown in black (each point represents an individual gene). The
highlighted genes are those with the greatest difference between observed and predicted values. The slopes for the seven individual
populations are shown in different colors. The Denver Chinese (D. Chinese) and Han Chinese (H. Chinese) are superimposed in such a way that
only one line is observed for both slopes.
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lation than in the CEPH population (Figure 3). The
mean proportion of individuals with a rare variant across
all genes is 0.101 for the Yoruba population and 0.072 for
the CEPH population (p <2 . 2×1 0
−16). For the average
number of rare variants per individual the values are
0.075 and 0.055, respectively (p < 2.2 × 10
−16).
In the analysis using only nonsynonymous SNPs, the
mean value of Tajima’s D for each population (see Table 1)
is more negative than when only synonymous SNPs are
used. In addition, in the nonsynonymous SNP analysis,
there are more genes with values of Tajima’s D less than
−2, the lower end of the theoretical 95% confidence
interval for this measure (compare Figures 4 and 5). Also,
the nonsynonymous SNPs analysis shows more consis-
tency: The genes show highly negative values of Tajima’s D
across populations; that is, the genes show an excess of
rare variants. This can be seen in the lower variance of the
values of Tajima’s D across populations that is obtained
through nonsynonymous SNPs (average = 0.18) compared
to the variance observed with the synonymous SNPs (aver-
age = 0.59) (see Table 2).
RANBP2 stands out as an exception to the consistency
in values of Tajima’s D across populations in the nonsy-
nonymous SNPs analysis. Excluding the Luhya popula-
tion, the average number of total variants across the
Table 1 Rare variant density and values of Tajima’s D across populations
Population Slope Mean Tajima’s D
Estimate Standard Error p-value Nonsynonymous SNPs Synonymous SNPs
Tuscan 0.576 0.005 3.30 × 10
−15 a −0.097 0.161
CEPH 0.626 0.004 5.90 × 10
−3a −0.151 0.140
Japanese 0.644 0.005 6.60 × 10
−8a −0.197 0.090
Han Chinese 0.677 0.004 9.33 × 10
−1 −0.296 −0.032
Denver Chinese 0.677 0.004 1.30 × 10
−3a −0.265 −0.028
Yoruba 0.694 0.003 8.80 × 10
−2 −0.461 −0.213
Luhya 0.701 0.003 <2.2 × 10
−16 a −0.444 −0.215
All 0.902 0.002
Rare variant to total variant slope estimates and standard errors are given for each population and for all the populations pooled. The populations are ranked
according to slope. Equality of slopes for contiguous populations (i.e., Tuscan vs. CEPH, CEPH vs. Japanese, etc.) is tested, and the p-value for each comparison is
given. Finally, the mean values of Tajima’s D for each population calculated on the basis of nonsynonymous and synonymous SNPs are given.
a Significant difference between the population and the one immediately below.
Figure 2 Comparison of rare variant density when using synonymous and nonsynonymous SNPs. Synonymous SNPs show greater
differentiation between the populations. D. Chinese, Denver Chinese; H. Chinese, Han Chinese.
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Page 4 of 9Figure 3 Measures of rare variant density used in rare variant case-control association analysis. Comparison of the distribution of rare
variants between the Yoruba and CEPH populations. Each point represents the value for one of the genes for both populations. The identity
lines are plotted to aid in the comparison.
Figure 4 Values of Tajima’s D less than −2 using nonsynonymous SNPs for all populations. Genes present in more than one population
are presented in color. D. Chinese, Denver Chinese; H. Chinese, Han Chinese.
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these variants are rare, and 75% of these rare variants
are nonsynonymous. The Luhya population, on the
other hand, has only one common variant for RANBP2.
A similar pattern is observed for RGPD4,w h e r et h e
mean number of total variants is 21.5 excluding the
Luhya. Eighty-five percent of these are rare, and 64% of
these rare variants are nonsynonymous. The Luhya
population has only three segregating sites for RGPD4,
two of which are rare variants.
Discussion
When comparing rare variant density between popula-
tions, investigators want to know whether the differences
are due to drift or selection. For instance, values of
Tajima’s D that are less than −2 may indicate positive
selection, whereas values greater than 2 may provide evi-
dence of balancing selection. But, under neutral theory,
selection can be inferred from Tajima’s D only if a bal-
ance between the mutation ra t ea n dt h er a t eo fa l l e l i c
fixation is assumed. This balance does not exist if the
population is going through a period of expansion or
contraction—demographic phenomena that can also
result in negative and positive values of Tajima’s D,
respectively—instead of selection. One way to distinguish
between demography and selection is that demography
affects the genome as a whole, whereas selection has a
differential effect on functional regions within the
genome.
Rare variant to total variant regression across the 3,205
genes distributed throughout the genome averages out the
differential effects of selection. Slope differences between
populations are a better reflection of the differences in
demographic phenomena that affect all genes for each
population. Populations group by continent for this para-
meter, with the African, European, and Asian populations
showing slopes with more similar values within continents.
The Japanese population is significantly different from
both the European and the Chinese populations. Mean
values of Tajima’s D for each population for both synon-
ymous and nonsynonymous SNPs group the populations
in the same manner, with the African populations showing
the greatest density of rare variants. Note that this does
not simply indicate higher and lower levels of overall var-
iation but rather higher and lower levels of rare variants
given the amount of total variation. Although the African
Figure 5 Values of Tajima’s D less than −1.8 using synonymous SNPs for all populations. Genes present in more than one population are
presented in color. D. Chinese, Denver Chinese; H. Chinese, Han Chinese.
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variation, they may also present greater levels of rare var-
iants, even after taking their overall level of variation into
account. In a study of one of the most sequenced genes in
humans, BRCA1, individuals with African ancestry were
shown to have a significantly higher proportion of deleter-
ious mutations compared to European Americans [7]. It
would be of interest to see whether this is a result that is
specific to this particular gene or whether it is product of
the demography of the African population, as suggested
by this study, and thereby reflected genome-wide. With
the advent of more affordable sequencing technologies,
the answer to this question can be pursued and may aid in
the study of the genetic epidemiology of cancer and health
disparities.
The outlier genes highlighted in Figure 1 are likely to
represent instances of selection because their rare variant
loads are distinct from that of other genes and is unlikely
to be due to demographic parameters. AHNAK,w h i c h
lies above the regression line, presents an excess of rare
variants compared to other genes and is likely under
positive selection; CDC27, PRR4,a n dHLA-A are under
the regression line, which means that they present an
excess of common variants and are likely under balancing
selection. The AHNAK gene encodes an unusually large
protein that is typically repressed in cell lines derived
from human neuroblastomas and in several other types
of tumors. AHNAK is known to be composed of highly
conserved repeated elements [8]. Regions in the genome
that are highly conserved are generally so because of the
selective pressure acting on them. At the other end of the
spectrum lies the human leukocyte antigen system
(HLA), the major histocompatibility complex in humans.
HLA loci are known to be exceptionally diverse. As
Apanius et al. [9] describe, only natural selection for het-
erozygosity can account for such a level of diversity.
Although the number of rare variants in relation to the
number of total variants or segregating sites is not a
Table 2 Statistics aggregated across populations
Gene Mean
Tajima’s D
Variance of
Tajima’s D
Total number of
variants
Proportion of rare
variants
Proportion of rare variants that are
nonsynonymous
Nonsynonymous
AHNAK −2.08 0.06 65.86 0.86 0.69
RELN −1.97 0.02 33.43 0.74 0.59
POLE −1.95 0.04 24.29 0.72 0.69
PIK3C2B −1.83 0.19 21.29 0.62 0.56
PKD1 −1.49 0.39 22.86 0.71 0.61
RANBP2 NA NA 24.57 0.82 NA
INVS −1.72 0.22 9.43 0.82 0.75
NPC1L1 −1.70 0.10 13.71 0.83 0.58
BAIAP3 −1.73 0.05 13.29 0.81 0.63
RGPD4 −1.16 0.83 18.86 0.83 0.62
CEP250 −1.59 0.06 17.14 0.85 0.65
ATM −1.38 0.19 5.29 0.95 0.77
GAB2 NA NA 9.14 0.54 NA
DNMBP −1.82 0.04 19.43 0.69 0.66
OR8H1 −1.24 0.29 6.86 0.63 0.93
CCDC63 −1.64 0.04 8.00 0.90 0.77
Average −1.66 0.18 19.59 0.77 0.68
Synonymous
TACC2 −1.20 0.36 36.71 0.67 0.63
FRMPD2 −1.21 0.48 14.14 0.78 0.47
VPS26A −1.33 0.36 0.57 NA NA
MDN1 −1.20 0.95 54.29 0.71 0.64
PTPRS −1.21 0.36 18.86 0.78 0.37
RGPD4 −1.62 0.13 18.86 0.83 0.62
C20ORF26 −0.89 1.48 21.71 0.73 0.71
H2AFY2 NA NA 3.29 NA NA
Average −1.24 0.59 21.05 0.75 0.57
Tajima’s D, its variance, total number of polymorphisms, and the proportions of rare and nonsynonymous variants are given for each of the genes that reflect the
most negative values of Tajima’s D (less than −2 for the analysis based on nonsynonymous SNPs and less than −1.8 for the analysis based on synonymous SNPs).
NA (not applicable) corresponds to instances in which the value is not defined for at least one of the populations.
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iant association analysis, Bansal et al. [1] pointed out that
summary group-level statistics such as this can poten-
tially be used along with individual-based measures. As
they pointed out, the use and power of such statistics
have not yet been assessed [1]. One possible drawback of
using group diversity measures in an association test is
that population substructure within the group can inflate
the statistic, as can be seen by the higher slope obtained
for the pooled populations (see Figure 1). Controlling for
this level of substructure would have to be considered in
any method that relies on such measures.
The group-level rare to total variant ratio, which is the
rare variant density measure investigated here for each
population, can translate into differences in number of
individuals who carry a rare variant and/or number of rare
variants per individual, measures more commonly used in
association analyses on rare variants [2]. Two assumptions
would have to hold for this translation: (1) The rare var-
iant distribution across individuals does not differ between
populations, and (2) the allele frequency spectrum for the
rare SNPs does not differ between populations. Without
testing these assumptions, we do see that the difference
between the Yoruba and CEPH populations is also present
for these measures (see Figure 3). Ancestry can therefore
be an important confounder for rare variant association
analysis in the same way it has proven to be for common
SNP associations in genome-wide association studies.
Simulations that study the best way to control for ancestry
for rare variant association analysis still have to be per-
formed. Admixed populations in particular may require a
local level of ancestry control in order to account for dif-
ferential rare variant densities throughout the genome.
This set of data does not afford much power for detect-
ing significant values of Tajima’s D for individual genes,
especially after accounting for multiple comparisons.
Despite this, carrying out separate analyses on synon-
ymous and nonsynonymous SNPs provides a way of seeing
a result that can best be explained by selection. If random
noise explained the rare variant distribution across the
genome seen in this data set, then synonymous SNPs
would necessarily present the same allele frequency spec-
trum as the nonsynonymous SNPs. Values of Tajima’s D
for both sets of SNPs would not systematically differ. Here
we see that they do; the nonsynonymous SNPs result in
more negative values of Tajima’s D for all the populations
(see Table 2). This may indicate an increase in power for
detecting instances of selection across the genome when
using the nonsynonymous SNPs, which are more likely to
have a functional effect relative to the synonymous SNPs.
If overall there are more instances of positive selection
(negative Tajima’s D) than of balancing selection (positive
Tajima’s D), then the increase in power would result
in the more negative mean value of Tajima’s D for the
population. This result is therefore a good indication that
the nonsynonymous SNP analysis of Tajima’s D is picking
up real signals of selection that are present in these data.
The contrast between the synonymous and nonsynon-
ymous SNPs rare to total variant regressions (see Figure 2)
also serves to distinguish whether selection or drift is
accounting for the results. The observed population slope
differences are likely caused by phenomena that affect the
genome as a whole, such as genetic drift. It is to be
expected, therefore, that because synonymous SNPs are
less sensitive to functional variation across the genome,
they can provide greater power for detecting these gen-
ome-wide differences caused by drift.
In this study we focus on the results for positive selec-
tion (excess of rare variants, negative values of Tajima’s
D) rather than for balancing selection (excess of common
variants, positive values of Tajima’s D) because of the
ascertainment bias that is present in the data. The SNP
discovery process presents a bias toward common SNPs
that has not been corrected for [10], making any infer-
ence on positive values of Tajima’s D extremely difficult.
Also, positive selection is likely to play a larger role
across the genome than balancing selection would.
Despite this, the rare variant to total variant regressions
present an alternative to biased values of Tajima’s D for
inferring balancing selection. The outliers under the
regression line clearly show an excess of common var-
iants that cannot be explained by ascertainment bias.
Finally, values of Tajima’s D provided by the nonsynon-
ymous SNP analysis should provide relatively low varia-
tion across populations if this analysis is indeed
improving the detection of functionally important genes.
It is a biology that is likely to translate across different
populations, and therefore the same genes should present
the more extreme values from population to population.
For the synonymous SNPs, on the other hand, genes are
more likely to present extreme values by chance alone,
and more variation across populations should be
expected. This is in fact what we see here, and it serves
as another indication that the nonsynonymous SNP ana-
lysis is picking up on real selection signal rather than ran-
dom noise.
If this is the case, we can use our analysis to compare
selection signals and what may be functionality across
populations. Table 2 shows that most genes that may be
presenting a selection signal have consistently highly nega-
tive values of Tajima’s D across all populations. One
exception to this rule is RANBP2. RANBP2, like AHNAK,
is a highly conserved gene. Its insufficiency has been
linked to autosomal dominant necrotizing encephalopathy,
among other things [11]. Not only is there evidence for
selection for the gene in itself, but the gene has also been
the object of extensive duplication in the human lineage,
with the resulting region occupying approximately 10% of
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RANBP2 within this region. This gene family has been
named RGP (RanBP2-like, GRIP domain containing pro-
teins) [12]. Evidence suggests that all eight copies are evo-
lutionarily active and are expressed [11]. This includes
RGPD4, the other gene in this study that showed the same
pattern as RANBP2.
Several possibilities can account for the striking differ-
ence between the rare variant load for the Luhya population
compared to the rest of the populations for these RGPD4
and RANBP2. Environmental differences can certainly
account for differences in selection pressure between popu-
lations even when the biology and functionality of the gene
remains unchanged from population to population. On the
other hand, the gene’s functionality itself may be different.
Genomic context, which plays a role in the functionality of
individual genes, can be greatly divergent between popula-
tions because of drift and other historical events, such as
deletions and duplications. This result points out a specific
instance in which it may be important to take into account
the ancestral composition of the study population when
attempting to narrow down genomic searches according to
functionality. It also underlines the potential for disease
heterogeneity across different populations.
Conclusions
Rare variant density differences exist between populations
because of differences in their demographic histories and
selection pressures. These differences have implications
for conducting rare variant association analyses and for
studies that attempt to use functionality as a means of
delimiting the genomic search space for associations. They
also bring to light the potential for disease heterogeneity
across different populations.
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